Compare KRRO & RVSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KRRO | RVSB |
|---|---|---|
| Founded | 2014 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 150.0M | 117.2M |
| IPO Year | 2019 | 1997 |
| Metric | KRRO | RVSB |
|---|---|---|
| Price | $13.67 | $5.54 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 1 |
| Target Price | ★ $34.80 | $7.00 |
| AVG Volume (30 Days) | ★ 197.4K | 35.0K |
| Earning Date | 05-06-2026 | 04-24-2026 |
| Dividend Yield | N/A | ★ 1.45% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.18 |
| Revenue | ★ $6,392,000.00 | N/A |
| Revenue This Year | N/A | $11.67 |
| Revenue Next Year | N/A | $14.55 |
| P/E Ratio | ★ N/A | $30.72 |
| Revenue Growth | ★ 181.46 | N/A |
| 52 Week Low | $5.20 | $4.74 |
| 52 Week High | $55.89 | $6.59 |
| Indicator | KRRO | RVSB |
|---|---|---|
| Relative Strength Index (RSI) | 59.66 | 54.53 |
| Support Level | $12.17 | $5.28 |
| Resistance Level | $15.11 | $5.77 |
| Average True Range (ATR) | 1.07 | 0.15 |
| MACD | 0.17 | 0.00 |
| Stochastic Oscillator | 67.20 | 51.32 |
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.
Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.